Published in Europace on August 25, 2006
NIPS to Identify High-risk Patients With ICD (NIPS-ICD) | NCT02373306
Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J (2009) 8.25
Rescue renal sympathetic denervation in a patient with ventricular electrical storm refractory to endo- and epicardial catheter ablation. Clin Res Cardiol (2014) 2.15
Is T-wave alternans testing feasible in candidates for prophylactic implantable defibrillators? Neth Heart J (2011) 1.89
Clinical experience with a novel subcutaneous implantable defibrillator system in a single center. Clin Res Cardiol (2011) 1.46
Implementation of guidelines for implantable cardioverter-defibrillator therapy in clinical practice: Which patients do benefit? Neth Heart J (2013) 1.35
ICDs at higher age and clinical risk factors. Neth Heart J (2014) 1.13
Risk stratification in individuals with the Brugada type 1 ECG pattern without previous cardiac arrest: usefulness of a combined clinical and electrophysiologic approach. Eur Heart J (2010) 1.10
Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson (2010) 1.02
A systematic review of ICD complications in randomised controlled trials versus registries: is our 'real-world' data an underestimation? Open Heart (2015) 0.97
The antiarrhythmic dipeptide ZP1609 (danegaptide) when given at reperfusion reduces myocardial infarct size in pigs. Naunyn Schmiedebergs Arch Pharmacol (2013) 0.96
First experience with the wearable cardioverter defibrillator in the Netherlands. Neth Heart J (2012) 0.94
Bleeding complications after pacemaker or cardioverter-defibrillator implantation in patients receiving dual antiplatelet therapy: Results of a prospective, two-centre registry. Neth Heart J (2010) 0.94
Sudden cardiac arrest in takotsubo cardiomyopathy - a case study. Postepy Kardiol Interwencyjnej (2014) 0.90
Incidence of sudden cardiac death in Germany: results from an emergency medical service registry in Lower Saxony. Europace (2014) 0.89
Targeting cardiomyocyte Ca2+ homeostasis in heart failure. Curr Pharm Des (2015) 0.87
Elevated plasma free fatty acids are associated with sudden death: a prospective community-based evaluation at the time of cardiac arrest. Heart Rhythm (2014) 0.87
Safe drug use in long QT syndrome and Brugada syndrome: comparison of website statistics. Europace (2013) 0.85
Cost-effectiveness of cardiac resynchronisation therapy for patients with moderate-to-severe heart failure: a lifetime Markov model. BMJ Open (2011) 0.84
Follow-up of implantable cardioverter-defibrillator therapy: comparison of coronary artery disease and dilated cardiomyopathy. Neth Heart J (2014) 0.83
Pre-hospital cooling of patients following cardiac arrest is effective using even low volumes of cold saline. Crit Care (2010) 0.82
Utility of electrophysiological studies to predict arrhythmic events. World J Cardiol (2015) 0.82
Use of external defibrillator jacket to facilitate safe delivery of radiotherapy for lung cancer - a report of two cases. Indian Heart J (2014) 0.81
Transseptal versus transaortic approach for radiofrequency ablation in patients with cardioverter-defibrillator and electrical storm. J Interv Card Electrophysiol (2010) 0.81
Association of psychiatric history and type D personality with symptoms of anxiety, depression, and health status prior to ICD implantation. Int J Behav Med (2013) 0.80
Prehospital cardiac arrest: a marker for higher mortality in patients with acute myocardial infarction and moderately reduced left ventricular function: results from the MITRA plus registry. Clin Res Cardiol (2008) 0.80
Arrhythmia risk in liver cirrhosis. World J Hepatol (2015) 0.79
Sleep quality and sleepiness in persons with implantable cardioverter defibrillators: outcome from a clinical randomized longitudinal trial. Pacing Clin Electrophysiol (2012) 0.79
External prolonged electrocardiogram monitoring in unexplained syncope and palpitations: results of the SYNARR-Flash study. Europace (2015) 0.78
Diagnosis, management, and outcomes of patients with syncope and bundle branch block. Eur Heart J (2011) 0.78
The ratio of the neutrophil leucocytes to the lymphocytes predicts the outcome after cardiac resynchronization therapy. Europace (2015) 0.78
COPE-ICD: a randomised clinical trial studying the effects and meaning of a comprehensive rehabilitation programme for ICD recipients -design, intervention and population. BMC Cardiovasc Disord (2011) 0.78
Role of myocardial perfusion single photon emission computed tomography in pediatric cardiology practice. Ann Pediatr Cardiol (2009) 0.78
Recurrent syncope associated with a distinct ECG pattern consisting of short QT interval, early repolarization and atrioventricular block. Clin Res Cardiol (2009) 0.77
3D X-ray imaging methods in support catheter ablations of cardiac arrhythmias. Int J Cardiovasc Imaging (2014) 0.77
Gender differences related to the presence of atrial fibrillation in older hypertensive patients. World J Cardiol (2013) 0.77
Unusual cause of syncope in young girl: arrhythmogenic right ventricular cardiomyopathy. Clin Res Cardiol (2010) 0.77
Impact of moderate exercise workload on predicted optimal AV and VV delays determined by an intracardiac electrogram-based method for optimizing cardiac resynchronization therapy. Clin Res Cardiol (2010) 0.77
[ICD therapy in the primary prevention of sudden cardiac death: Risk stratification and patient selection]. Herzschrittmacherther Elektrophysiol (2015) 0.76
Ventricular fibrillation cardiac arrest due to 5-fluorouracil cardiotoxicity. Tex Heart Inst J (2013) 0.76
Assessing the outcomes of implantable cardioverter defibrillator treatment in a real world setting: results from hospital record data. BMC Health Serv Res (2013) 0.76
A patient with severely reduced LV function and electrical storm saved by wearable cardioverter-defibrillator: a case report. Herzschrittmacherther Elektrophysiol (2013) 0.76
[Primary and secondary prophylactic ICD therapy in congenital electrical and structural cardiomyopathies]. Herzschrittmacherther Elektrophysiol (2015) 0.76
The utility of pocket-sized echocardiography to assess left ventricular systolic function prior to permanent pacemaker implantation. Cardiovasc Ultrasound (2015) 0.76
Rotational angiography of left ventricle to guide ventricular tachycardia ablation. Int J Cardiovasc Imaging (2015) 0.76
Predictors of Long-Term Outcome in Children with Hypertrophic Cardiomyopathy. Pediatr Cardiol (2015) 0.75
Influence of time between last myocardial infarction and prophylactic implantable defibrillator implant on device detections and therapies. "Routine Practice" data from the SEARCH MI registry. BMC Cardiovasc Disord (2012) 0.75
Prevalence and clinical relevance of the morphological substrate of ventricular arrhythmias in patients without known cardiac conditions detected by cardiovascular MR. Br J Radiol (2014) 0.75
Brugada syndrome with a novel missense mutation in SCN5A gene: a case report from Bangladesh. Indian Heart J (2013) 0.75
Flecainide: Current status and perspectives in arrhythmia management. World J Cardiol (2015) 0.75
A feasibility study of arrhythmia risk prediction in patients with myocardial infarction and preserved ejection fraction. Europace (2016) 0.75
Upgrade from ICD to CRT-D: clinical and haemodynamic impact of biventricular pacing in a patient with acquired long QT syndrome. Open Med (Wars) (2015) 0.75
Cardioverter-defibrillator implantation in myeloma-associated cardiac amyloidosis. Exp Clin Cardiol (2013) 0.75
Prognostic impact of early ventricular fibrillation in patients with ST-elevation myocardial infarction treated with primary PCI. Eur Heart J Acute Cardiovasc Care (2012) 0.75
Impact of Magnesium L-Lactate on Occurrence of Ventricular Arrhythmias in Patients with Implantable Cardioverter Defibrillators: A Randomized, Placebo-Controlled Trial. Open Cardiovasc Med J (2015) 0.75
Late presentation of arrhythmogenic right ventricular cardiomyopathy: a case report. J Med Case Rep (2009) 0.75
Frequent Ventricular Ectopics in a Healthy Adult Woman - is it Associated with Sudden Cardiac Death? Malays Fam Physician (2008) 0.75
Mortality and predictors of appropriate implantable cardioverter defibrillator therapy in Japanese patients with Multicenter Automatic Defibrillator Implantation Trial II criteria. J Arrhythm (2016) 0.75
Interdisciplinary Approach in a Complex Case of STEMI. Maedica (Buchar) (2014) 0.75
ICD Therapy for Primary Prevention in Hypertrophic Cardiomyopathy. Arrhythm Electrophysiol Rev (2016) 0.75
Do elderly patients benefit from implantable-cardioverter defibrillators? Neth Heart J (2014) 0.75
Ventricular tachycardia as the first manifestation of cardiac sarcoidosis. BMJ Case Rep (2009) 0.75
Usefulness of microvolt T-wave alternans testing in the assessment of all-cause mortality and life-threatening ventricular arrhythmia risk in patients with left ventricular dysfunction. Arch Med Sci (2014) 0.75
Improve the prevention of sudden cardiac arrest in emerging countries: the Improve SCA clinical study design. Europace (2015) 0.75
Extraction of a dual-chamber pacemaker and inserting of a new automatic implantable cardioverter defibrillator: The easy procedure almost became catastrophic: a case report. Medicine (Baltimore) (2017) 0.75
[Cardiac syncope : diagnosis and therapy]. Herzschrittmacherther Elektrophysiol (2011) 0.75
Sudden cardiac death in the young: how can disease recognition and prevention in family members be improved? Herzschrittmacherther Elektrophysiol (2012) 0.75
[What is new in the 2009 ESC guidelines?]. Herzschrittmacherther Elektrophysiol (2011) 0.75
[Severe ventricular arrhythmias in a patient with dilated cardiomyopathy and automated implantable defibrillator (AID)]. Pan Afr Med J (2017) 0.75
Rationale and design of the SPICE study-septal positioning of ventricular ICD electrodes. J Interv Card Electrophysiol (2011) 0.75
[ICD therapy as secondary prevention]. Herzschrittmacherther Elektrophysiol (2010) 0.75
Ventricular Arrhythmia after Acute Myocardial Infarction: 'The Perfect Storm'. Arrhythm Electrophysiol Rev (2017) 0.75
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation (2005) 43.74
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet (2004) 42.12
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med (2011) 28.99
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation (2004) 23.07
Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation (2004) 20.67
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09
Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation (2010) 19.30
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J (2012) 18.18
Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med (2009) 18.03
Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med (2007) 17.85
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 17.18
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J (2010) 16.39
Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA (2009) 13.69
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet (2008) 13.34
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25
Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association. Circulation (2004) 13.07
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73
Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr (2003) 11.88
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 11.88
Universal definition of myocardial infarction. Circulation (2007) 11.69